Chad Bousman

Associate Professor

University of Calgary

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (11)

José Agundez

Institute Chairman & Full Professor

Lisa Brown, PhD

UNITED STATES

Laura B. Ramsey

UNITED STATES

James Stevenson

Assistant Professor, Clinical Pharmacology

Johns Hopkins University

UNITED STATES

Abdullah Al Maruf

Jeffrey Strawn

University of Cincinnati

UNITED STATES

Robert Stowe

Clinical Professor

The University of British Columbia

Carl Kirkpatrick

MONASH UNIVERSITY

Suresh Sundram

MONASH UNIVERSITY

Vanessa Cropley

Henry M Dunnenberger

NorthShore University HealthSystem

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chad Bousman

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (11)

José Agundez

Lisa Brown, PhD

Laura B. Ramsey

James Stevenson

Abdullah Al Maruf

Jeffrey Strawn

Robert Stowe

Carl Kirkpatrick

Suresh Sundram

Vanessa Cropley

Henry M Dunnenberger

Make your next move.

Chad Bousman

Research Interests

Explore related searches

Contact this professor

Articles (19)

Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia

DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review

Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada

Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine

Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia

Effect of CYP2D6 genetic variation on patient-reported symptom improvement and side effects among children and adolescents treated with amphetamines

Predictors of the placebo response in a nutraceutical randomizedcontrolled trial for depression

Recommendations for pharmacogenetic testing in clinical practice guidelines in the US

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia

PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting

Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review

Dispensing patterns of mental health medications before and during the COVID-19 pandemic in Alberta, Canada: An interrupted time series analysis

Perturbed iron biology in the prefrontal cortex of people with schizophrenia

Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A

The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review

Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials

Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals

Pharmacogenomics in psychiatry – the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing

Collaborators (11)

José Agundez

Lisa Brown, PhD

Laura B. Ramsey

James Stevenson

Abdullah Al Maruf

Jeffrey Strawn

Robert Stowe

Carl Kirkpatrick

Suresh Sundram

Vanessa Cropley

Henry M Dunnenberger

Make your next move.